12/10/2026
🎀 October | Breast Cancer Awareness Month
For patients undergoing cancer treatment, reliable central venous access is an important part of the treatment journey.
Protect Port-a-Cath from day one with TauroLock™ HEP 100.
Biofilm formation can compromise central venous access and contribute to catheter-related complications. Protecting the catheter and maintaining its function are therefore important considerations throughout therapy.
At Paxton LLC, we remain committed to supporting safer, reliable vascular access care for oncology patients.
💗 Because every detail of supportive care matters.